Investors bet millions more on Raleigh firm’s EpiPen alternative


A pharmaceutical company in Raleigh is adding to a recent multimillion-dollar raise as investors bet on its EpiPen alternative.

Previous Yelp names Durham vegan restaurant best in the Carolinas
Next Economic impact study reports Nashville health care as $68 billion industry